Accessibility settings

This paper is in the following e-collection/theme issue:

Research Letter (239) E-Health Policy and Health Systems Innovation (509) Business and Entrepreneurship in eHealth (67) Pharmacology and Pharmaceutics (158) Artificial Intelligence (4564) Precision Medicine (423) Drug Discovery and Clinical Trials (24) Drug discovery and development (16)

Published on in Vol 28 (2026)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/84968, first published .
Scientist in lab coat and gloves examines vial next to microscope and test tubes.

Trends in Venture Capital Investment in AI-Driven Biopharmaceutical Startups

Trends in Venture Capital Investment in AI-Driven Biopharmaceutical Startups

Authors of this article:

Abhishek Bazaz1 Author Orcid Image ;   Yunan Ji2 Author Orcid Image ;   Mariana P Socal3, 4 Author Orcid Image ;   So-Yeon Kang5 Author Orcid Image
Article Authors Cited by (1) Tweetations (2) Metrics

Journals

  1. Szalay T. Impact of No-Code AI Drug Discovery Platforms on the Operational Cost Structure of Biotechnology Ventures. Universal Library of Business and Economics 2026;3(3):01 View